Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Antiviral agents

Naturally occurring peptides show antiviral potential against common cold

Cathelicidins could be a new therapeutic strategy for the management of human rhinovirus infection, researchers suggest.

Coloured transmission electron micrograph (TEM) of rhinoviruses particles infecting nasal epithelial cells of the nose

Source: Dennis Kunkel Microscopy / Science Photo Library

Researchers decided to investigate the antiviral potential of cathelicidins against human rhinovirus infection.

Human rhinoviruses (HRV) are the most common cause of viral respiratory tract infections, but there are no current effective treatments for HRV infection and development of an effective vaccine has thus been shown to be almost impossible.

Cathelicidins are antimicrobial peptides known to possess broad-spectrum antimicrobial and antiviral activity against a wide range of bacterial and viral pathogens, so researchers decided to investigate their antiviral potential against HRV.

In an in vitro model of HRV infection they found that the human cathelicidin LL-37, the porcine cathelicidin Protegrin-1 and the ovine cathelicidin SMAP-29 displayed powerful and direct antiviral activity towards HRV both prior to cell infection and after. The cathelicidins were observed to work directly against the virion rather than by the induction of cell death in the host airway cells.

Reporting in Peptides (online, 29 July 2017), the researchers conclude that following further research, cathelicidins could represent a novel therapeutic strategy for the management of HRV infection in future[1].

Citation: Clinical Pharmacist DOI: 10.1211/CP.2017.20203556

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Chronotherapeutics

    Chronotherapeutics

    Chronotherapeutics discusses the pharmaceutical and therapeutic implications associated with biological clocks in humans.

    £37.00Buy now
  • Disease Management

    Disease Management

    Disease Management covers the diseases commonly encountered in primary care by system, with common therapeutic issues. Includes case studies and self-assessment sections.

    £52.00Buy now
  • FASTtrack: Therapeutics

    FASTtrack: Therapeutics

    FASTtrack: Therapeutics is a revision book for pharmacy students. It covers all the main systems of the body with a summary of therapeutics.

    £24.00Buy now
  • Introduction to Renal Therapeutics

    Introduction to Renal Therapeutics

    Introduction to Renal Therapeutics covers all aspects of drug use in renal failure. Shows the role of the pharmacist in patient care for chronic kidney disease.

    £37.00Buy now
  • Biological Therapeutics

    Biological Therapeutics

    An introduction to the treatment of disease using biological medicines derived from living plant and animal tissues.

    £32.00Buy now
  • Pathology and Therapeutics for Pharmacists

    Pathology and Therapeutics for Pharmacists

    An practical, integrated approach to the pathophysiological and pharmacotherapeutic principles underlying the treatment of disease.

    £52.00Buy now

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • Coloured transmission electron micrograph (TEM) of rhinoviruses particles infecting nasal epithelial cells of the nose

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.